Contributors |
|
vii | |
1 Stability of Regulatory T-cell Lineage |
|
1 | (24) |
|
|
|
2 | (1) |
|
|
3 | (2) |
|
2.1 Thymus-derived CD25+CD4+ Treg cells |
|
|
3 | (2) |
|
2.2 Foxp3 and its essential role in Treg cells |
|
|
5 | (1) |
|
3 Differentiation and Functional Adaptation of Foxp3+ Treg Cells |
|
|
5 | (2) |
|
3.1 Intrathymic differentiation |
|
|
5 | (1) |
|
3.2 Extrathymic differentiation |
|
|
6 | (1) |
|
3.3 Functional adaptation |
|
|
7 | (1) |
|
4 Regulation of Treg Cell Differentiation by Foxp3 |
|
|
7 | (3) |
|
4.1 Role of Foxp3 in Treg cell differentiation |
|
|
7 | (1) |
|
4.2 Mechanisms of Foxp3 induction and maintenance |
|
|
8 | (2) |
|
5 Controversies Over Stability Versus Plasticity of the Treg Cell Lineage |
|
|
10 | (6) |
|
5.1 Evidence for plasticity of Foxp3+T cells |
|
|
10 | (3) |
|
5.2 Evidence against the plasticity phenomena |
|
|
13 | (1) |
|
5.3 Toward reconciliation |
|
|
14 | (2) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (9) |
2 Thymic and Peripheral Differentiation of Regulatory T Cells |
|
25 | (48) |
|
|
|
|
|
26 | (1) |
|
2 Thymic Development of Treg Cells |
|
|
26 | (20) |
|
|
26 | (2) |
|
2.2 Intrinsic factors involved in thymic Treg cell development |
|
|
28 | (15) |
|
2.3 Extrinsic factors for the thymic Treg cell differentiation |
|
|
43 | (3) |
|
3 Peripheral Treg Cell Development |
|
|
46 | (12) |
|
|
46 | (2) |
|
|
48 | (7) |
|
|
55 | (3) |
|
|
58 | (1) |
|
|
59 | (14) |
3 Regulatory T Cells in Infection |
|
73 | (64) |
|
|
|
|
74 | (1) |
|
|
74 | (2) |
|
|
76 | (29) |
|
|
76 | (6) |
|
|
82 | (7) |
|
|
89 | (7) |
|
|
96 | (7) |
|
|
103 | (2) |
|
4 Treg Activation-A Common Immune-Evasion Strategy Achieved Through Diverse Routes |
|
|
105 | (5) |
|
4.1 Direct conversion of T cells into Tregs |
|
|
106 | (1) |
|
4.2 Induction of Tregs via DCs |
|
|
107 | (1) |
|
4.3 Bystander induction by other cell types |
|
|
108 | (1) |
|
4.4 TLRs in Treg activation |
|
|
108 | (2) |
|
5 Antigen Specificity of Natural and Adaptive Tregs in Infection |
|
|
110 | (2) |
|
6 Tregs and the Hygiene Hypothesis |
|
|
112 | (1) |
|
|
113 | (2) |
|
|
115 | (1) |
|
|
115 | (22) |
4 Biological Functions of Regulatory T Cells |
|
137 | (40) |
|
|
|
138 | (1) |
|
2 Biologic Functions of Polyclonal Tregs in Vivo |
|
|
139 | (13) |
|
2.1 Polyclonal Tregs inhibits the induction of disease in immunodeficient mice |
|
|
140 | (1) |
|
2.2 Polyclonal Tregs suppress disease induced by fully activated Teff in immunodeficient mice |
|
|
141 | (4) |
|
2.3 Effects of polyclonal Tregs on T cell activation in immunocompetent mice |
|
|
145 | (4) |
|
2.4 Effect of Polyclonal Tregs on antibody production |
|
|
149 | (3) |
|
3 Biologic Effects of Antigen-Specific Tregs In Vivo |
|
|
152 | (18) |
|
3.1 Isolation of antigen-specific Foxp3+T cells |
|
|
152 | (1) |
|
3.2 Generation of antigen-specific Foxp34-T cells in vitro |
|
|
153 | (1) |
|
3.3 Suppression of immune responses in vivo by iTregs |
|
|
154 | (1) |
|
3.4 Treatment of organ-specific autoimmune disease with antigen-specific iTregs |
|
|
155 | (4) |
|
3.5 Antigen-specific iTregs inhibit Th17-induced AIG |
|
|
159 | (2) |
|
3.6 Mechanistic analysis of the biologic effects of antigen-specific Tregs in vivo |
|
|
161 | (5) |
|
3.7 Biologic effects of Tregs on DC functions |
|
|
166 | (4) |
|
4 Conclusions and Speculations |
|
|
170 | (2) |
|
|
172 | (1) |
|
|
172 | (5) |
5 Extrathymic Generation of Regulatory T Cells-Chances and Challenges for Prevention of Autoimmune Disease |
|
177 | (38) |
|
|
|
|
178 | (3) |
|
1.1 Historical perspective of dominant tolerance executed by Foxp3+ regulatory T cells |
|
|
178 | (3) |
|
2 Intra- and Extrathymic Induction of Foxp3+ Tregs |
|
|
181 | (10) |
|
2.1 Requirements for i.t. differentiation of Foxp3+ Tregs |
|
|
181 | (5) |
|
2.2 Requirements for e.t. generation of Foxp3+ Tregs |
|
|
186 | (2) |
|
2.3 Signaling pathways and regulatory DNA elements controlling Foxp3 expression |
|
|
188 | (1) |
|
2.4 PI3K–mTOR–Akt signaling pathway-Role in e.t. Treg generation and function |
|
|
189 | (2) |
|
3 Enhancement of e.t. Treg Generation |
|
|
191 | (2) |
|
4 Tolerogenic Vaccination by Strong-Agonist Mimetopes of Self-Antigens in Order to Prevent Autoimmune Disease |
|
|
193 | (6) |
|
4.1 Characteristics of autoreactive T cell epitopes and generation of Foxp3+ Tregs |
|
|
193 | (6) |
|
|
199 | (3) |
|
|
202 | (1) |
|
|
202 | (13) |
Index |
|
215 | (4) |
Contents of Recent Volumes |
|
219 | |